Influenza continues to be an important cause of preventable morbidity and mortality.
Although influenza vaccine is widely recommended for older high-risk individuals, no studies have compared its use in different countries.
We gathered information on influenza vaccine distribution in 18 developed countries for the period 1980-1992.
During the 1980s there was a = 10-fold difference in annual per capita vaccine distribution among these countries, and in 1992 the difference was still more than 7-fold.
Several countries demonstrated large increases in vaccine use over the study period, some showing substantial increases in specific years.
Thirteen of the 18 countries recommend influenza vaccination for all elderly persons and 11 countries provide reimbursement for vaccination through national or social health insurance.
These countries tend to have higher levels of vaccine use.
Historical, economic and political factors also affect vaccination practices and policies, but their relationships to differences in vaccine use between countries are not known.
A better understanding of why the use of influenza vaccine varies among countries will be important if its protective benefits are to be fully realized.
Mots-clés Pascal : Influenzavirus, Orthomyxoviridae, Virus, Vaccination, Homme, Vieillard, Immunoprotection, Prévention, Etude multicentrique, Utilisation, Politique sanitaire, Remboursement
Mots-clés Pascal anglais : Influenzavirus, Orthomyxoviridae, Virus, Vaccination, Human, Elderly, Immunoprotection, Prevention, Multicenter study, Use, Health policy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0093952
Code Inist : 002B05C02C. Création : 199608.